Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
350 | 35656 | 37.4 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
350 | 3 | COMPLEMENT//MANNOSE BINDING LECTIN//IMMUNOLOGY | 35656 |
363 | 2 | COMPLEMENT//MANNOSE BINDING LECTIN//PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | 17354 |
1655 | 2 | BIOSIMILAR//FCRN//PROTEIN FORMULATION | 6878 |
2797 | 2 | FC RECEPTOR//FC GAMMA RECEPTORS//FC GAMMA RECEPTOR | 3097 |
2906 | 2 | SIGLEC//TREM2//TREM 1 | 2784 |
3004 | 2 | STAPHYLOCOCCAL PROTEIN A//PROTEIN A//ANIM PHYSIOL SECT | 2551 |
3191 | 2 | SECRETORY COMPONENT//POLYMERIC IMMUNOGLOBULIN RECEPTOR//CD89 | 2110 |
3862 | 2 | IGY//EGG YOLK ANTIBODIES//IMMUNOGLOBULIN Y | 882 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | COMPLEMENT | authKW | 676778 | 6% | 40% | 2003 |
2 | MANNOSE BINDING LECTIN | authKW | 244068 | 1% | 73% | 390 |
3 | IMMUNOLOGY | WoSSC | 210987 | 37% | 2% | 13299 |
4 | PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | authKW | 169430 | 1% | 81% | 246 |
5 | BIOSIMILAR | authKW | 141103 | 1% | 58% | 285 |
6 | ECULIZUMAB | authKW | 134690 | 1% | 77% | 206 |
7 | MOLECULAR IMMUNOLOGY | journal | 130469 | 3% | 15% | 1041 |
8 | FC RECEPTOR | authKW | 118671 | 1% | 39% | 354 |
9 | CD59 | authKW | 114177 | 1% | 66% | 203 |
10 | FACTOR H | authKW | 99402 | 0% | 65% | 178 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Immunology | 210987 | 37% | 2% | 13299 |
2 | Biochemistry & Molecular Biology | 10693 | 18% | 0% | 6551 |
3 | Rheumatology | 8930 | 3% | 1% | 1130 |
4 | Biochemical Research Methods | 6823 | 6% | 1% | 1974 |
5 | Hematology | 5669 | 5% | 1% | 1657 |
6 | Medicine, Research & Experimental | 5293 | 6% | 1% | 2034 |
7 | Pathology | 2110 | 3% | 0% | 1030 |
8 | Pharmacology & Pharmacy | 1992 | 7% | 0% | 2532 |
9 | Urology & Nephrology | 1826 | 3% | 0% | 1020 |
10 | Cell Biology | 1376 | 5% | 0% | 1910 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | LATE STAGE PHARMACEUT DEV | 32790 | 0% | 80% | 48 |
2 | PROT ANALYT CHEM | 28680 | 0% | 53% | 63 |
3 | IMMUNOL | 28459 | 5% | 2% | 1700 |
4 | COMPLEMENT BIOL GRP | 25873 | 0% | 70% | 43 |
5 | SERV IMMUNOL BIOL | 23631 | 0% | 34% | 82 |
6 | ENZYMOL MOL | 22863 | 0% | 62% | 43 |
7 | ANALYT FORMULAT SCI | 22774 | 0% | 68% | 39 |
8 | COMPLEMENT INFLAMMAT | 22749 | 0% | 54% | 49 |
9 | PROC PROD DEV | 20031 | 0% | 44% | 54 |
10 | MACROMOL VACCINE STABILIZAT | 17425 | 0% | 55% | 37 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | MOLECULAR IMMUNOLOGY | 130469 | 3% | 15% | 1041 |
2 | JOURNAL OF IMMUNOLOGY | 83379 | 7% | 4% | 2320 |
3 | MABS | 57937 | 1% | 30% | 224 |
4 | COMPLEMENT AND INFLAMMATION | 43996 | 0% | 79% | 65 |
5 | JOURNAL OF IMMUNOLOGICAL METHODS | 33095 | 2% | 6% | 620 |
6 | CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 28109 | 2% | 6% | 618 |
7 | IMMUNOLOGY | 27296 | 2% | 6% | 537 |
8 | BIOANALYSIS | 24438 | 1% | 14% | 201 |
9 | SCANDINAVIAN JOURNAL OF IMMUNOLOGY | 20937 | 1% | 7% | 376 |
10 | IMMUNOBIOLOGY | 19764 | 1% | 9% | 274 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | COMPLEMENT | 676778 | 6% | 40% | 2003 | Search COMPLEMENT | Search COMPLEMENT |
2 | MANNOSE BINDING LECTIN | 244068 | 1% | 73% | 390 | Search MANNOSE+BINDING+LECTIN | Search MANNOSE+BINDING+LECTIN |
3 | PAROXYSMAL NOCTURNAL HEMOGLOBINURIA | 169430 | 1% | 81% | 246 | Search PAROXYSMAL+NOCTURNAL+HEMOGLOBINURIA | Search PAROXYSMAL+NOCTURNAL+HEMOGLOBINURIA |
4 | BIOSIMILAR | 141103 | 1% | 58% | 285 | Search BIOSIMILAR | Search BIOSIMILAR |
5 | ECULIZUMAB | 134690 | 1% | 77% | 206 | Search ECULIZUMAB | Search ECULIZUMAB |
6 | FC RECEPTOR | 118671 | 1% | 39% | 354 | Search FC+RECEPTOR | Search FC+RECEPTOR |
7 | CD59 | 114177 | 1% | 66% | 203 | Search CD59 | Search CD59 |
8 | FACTOR H | 99402 | 0% | 65% | 178 | Search FACTOR+H | Search FACTOR+H |
9 | FCRN | 98947 | 0% | 85% | 137 | Search FCRN | Search FCRN |
10 | COMPLEMENT SYSTEM | 94776 | 1% | 41% | 270 | Search COMPLEMENT+SYSTEM | Search COMPLEMENT+SYSTEM |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | MERLE, NS , CHURCH, SE , FREMEAUX-BACCHI, V , ROUMENINA, LT , (2015) COMPLEMENT SYSTEM PART I - MOLECULAR MECHANISMS OF ACTIVATION AND REGULATION.FRONTIERS IN IMMUNOLOGY. VOL. 6. ISSUE . P. - | 265 | 81% | 61 |
2 | KLOS, A , WENDE, E , WAREHAM, KJ , MONK, PN , (2013) INTERNATIONAL UNION OF PHARMACOLOGY. LXXXVII. COMPLEMENT PEPTIDE C5A, C4A, AND C3A RECEPTORS.PHARMACOLOGICAL REVIEWS. VOL. 65. ISSUE 1. P. 500-543 | 350 | 66% | 59 |
3 | MERLE, NS , NOE, R , HALBWACHS-MECARELLI, L , FREMEAUX-BACCHI, V , ROUMENINA, LT , (2015) COMPLEMENT SYSTEM PART II: ROLE IN IMMUNITY.FRONTIERS IN IMMUNOLOGY. VOL. 6. ISSUE . P. - | 178 | 67% | 55 |
4 | THIEL, S , ANDERSEN, GR , BAJIC, G , DEGN, SE , (2015) COMPLEMENT ACTIVATION, REGULATION, AND MOLECULAR BASIS FOR COMPLEMENT-RELATED DISEASES.EMBO JOURNAL. VOL. 34. ISSUE 22. P. 2735 -2757 | 177 | 84% | 16 |
5 | RICKLIN, D , HAJISHENGALLIS, G , YANG, K , LAMBRIS, JD , (2010) COMPLEMENT: A KEY SYSTEM FOR IMMUNE SURVEILLANCE AND HOMEOSTASIS.NATURE IMMUNOLOGY. VOL. 11. ISSUE 9. P. 785-797 | 113 | 68% | 939 |
6 | BOLDT, ABW , GOELDNER, I , DE MESSIAS-REASON, IJT , (2012) RELEVANCE OF THE LECTIN PATHWAY OF COMPLEMENT IN RHEUMATIC DISEASES.ADVANCES IN CLINICAL CHEMISTRY, VOL 56. VOL. 56. ISSUE . P. 105-153 | 229 | 84% | 2 |
7 | KLOS, A , TENNER, AJ , JOHSWICH, KO , AGER, RR , REIS, ES , KOHL, J , (2009) THE ROLE OF THE ANAPHYLATOXINS IN HEALTH AND DISEASE.MOLECULAR IMMUNOLOGY. VOL. 46. ISSUE 14. P. 2753-2766 | 189 | 76% | 185 |
8 | GIRAGOSSIAN, C , CLARK, T , PICHE-NICHOLAS, N , BOWMAN, CJ , (2013) NEONATAL FC RECEPTOR AND ITS ROLE IN THE ABSORPTION, DISTRIBUTION, METABOLISM AND EXCRETION OF IMMUNOGLOBULIN G-BASED BIOTHERAPEUTICS.CURRENT DRUG METABOLISM. VOL. 14. ISSUE 7. P. 764-790 | 226 | 74% | 14 |
9 | RAM, S , LEWIS, LA , RICE, PA , (2010) INFECTIONS OF PEOPLE WITH COMPLEMENT DEFICIENCIES AND PATIENTS WHO HAVE UNDERGONE SPLENECTOMY.CLINICAL MICROBIOLOGY REVIEWS. VOL. 23. ISSUE 4. P. 740 -+ | 253 | 60% | 86 |
10 | GARRED, P , GENSTER, N , PILELY, K , BAYARRI-OLMOS, R , ROSBJERG, A , MA, YJ , SKJOEDT, MO , (2016) A JOURNEY THROUGH THE LECTIN PATHWAY OF COMPLEMENTMBL AND BEYOND.IMMUNOLOGICAL REVIEWS. VOL. 274. ISSUE 1. P. 74 -97 | 169 | 87% | 1 |
Classes with closest relation at Level 3 |